AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study NCT05243485 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: PreHEART
Description: The PreHEART score is validated for use in the pre-hospital setting.The score can be calculated based on five different elements: history, ECG, age, gender, and a Point-of-Care (POC)-Troponin. A minimum of 0 points and a maximum of 2 points can be scored in each element, the total PreHEART can contain a maximum of 10 points. The score of the history is based on the symptoms of the patient in accordance with the symptoms of a myocardial infarction. Based on the suspicion of ischemia on the ECG. Age will be based on the date of birth. Compared to the female gender, the male gender has higher risk of developing myocardial infarction and will be scored higher. The biomarker Troponin will be collected via intravenous access and measured using a POC-analyzer I-Stat from Abbott industries. In total 17 µl of blood is required to fill a cardiac Troponin I (cTnI) cartridge. Analyzing the blood will take approximately 10 minutes.
Study NCT06625489 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: GSK3915393
Description: GSK3915393 will be administered.
Study NCT06618651 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: SHR-3821 injection
Description: SHR-3821 injection
Study NCT06625814 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Levothyroxine
Description: single oral dose
Study NCT06625814 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Enlicitide Decanoate
Description: single oral dose
Study NCT06692673 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Use of Linaclotide as a single agent Colonoscopy prep
Description: We plan to conduct a pilot study to determine the feasibility of a quality bowel preparation with two 290mg doses of Linaclotide (first dose given 36 hours before, and the other 8 hours prior to the procedure) along with 2 Liters of Gatorade (to prevent dehydration) given the day prior to the colonoscopy instead of the current standard 4 liters of PEG regimen. All study participants will be asked to consume a clear liquid diet for 24hours before the procedure.
Study NCT05260008 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: ATX-101
Description: ATX-101 (bupivacaine) implant, one-time administration into the surgical site
Study NCT05260008 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: bupivacaine hydrochloride without epinephrine
Description: bupivacaine hydrochloride (125 mg) without epinephrine via local infiltration and/or nerve block
Study NCT06695494 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: Gene panel array
Description: Blood sample collection for gene panel testing
Study NCT06695494 — intervention group
Intervention type: OTHER
Intervention: Blood Sample Collection
Description: Blood sample collection for research purposes
Study NCT05931393 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Cabozantinib 80 MG
Description: cabozantinib 80mg daily
Study NCT04732416 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: HM15136
Description: Low dose of HM15136/ High dose of HM15136, SC injection, weekly
Study NCT06105164 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Repetitive Transcranial Magnetic Stimulation (rTMS)
Description: rTMS is a technique of TMS that allows for selective external manipulation of neural activity in a non-invasive manner. During rTMS a rapidly changing current is passed through an insulated coil placed against the scalp. This generates a temporary magnetic field, which in turn induces electrical current in neurons and allows for modulation of neural circuitry.~Intermittent theta burst stimulation (iTBS) consisting of 2 s trains of 3 pulses at 50 Hz, repeated at 5 Hz, every 10s for a total of 600 pulses (82), will be applied to the target. Cerebellar stimulation will be applied to the targets at 100% of aMT or 35% maximal stimulator output, whichever is higher.
Study NCT06105164 — intervention group
Intervention type: DEVICE
Group type: SHAM_COMPARATOR
Intervention: Sham repetitive Transcranial Magnetic Stimulation (rTMS)
Description: rTMS is a technique of TMS that allows for selective external manipulation of neural activity in a non-invasive manner. During rTMS a rapidly changing current is passed through an insulated coil placed against the scalp. This generates a temporary magnetic field, which in turn induces electrical current in neurons and allows for modulation of neural circuitry.~Intermittent theta burst stimulation (iTBS) consisting of 2 s trains of 3 pulses at 50 Hz, repeated at 5 Hz, every 10s for a total of 600 pulses (82), will be applied to the target. Cerebellar stimulation will be applied to the targets at 100% of aMT or 35% maximal stimulator output, whichever is higher.~Sham is achieved by using a coil with a magnetic shield preventing magnetic field from reaching the head.
Study NCT05275972 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Ripasudil
Description: Topical Ripasudil 0.4%
Study NCT05275972 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Topical Placebo
Study NCT06697496 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: QuitBot Smoking Cessation Chatbot Program
Description: Participate in Quitbot chatbot program
Study NCT06697496 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: QuitBot Smoking Cessation Text Messaging Program
Description: Participate in Quitbot texting program
Study NCT06697496 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Survey Administration
Description: Ancillary studies
Study NCT06697496 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Survey Administration
Description: Ancillary studies
Study NCT06697496 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Interview
Description: Ancillary studies
Study NCT06697496 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Interview
Description: Ancillary studies
Study NCT06697496 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Carbon Monoxide Measurement
Description: Ancillary studies
Study NCT06697496 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Carbon Monoxide Measurement
Description: Ancillary studies
Study NCT06693258 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: thyroidectomy by robotic surgery via axillary approach
Description: thyroidectomy
Study NCT06693258 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: thyroidectomy by standard conventional surgery
Description: thyroidectomy by standard conventional surgery
Study NCT06702592 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Virtual support
Description: Subjects will use a virtual support platform that was built for their needs.
Study NCT06702592 — intervention group
Intervention type: BEHAVIORAL
Group type: OTHER
Intervention: Patient educational material
Description: Participants will have access to patient educational material.
Study NCT06706622 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Lu AF82422
Description: Solution for infusion
Study NCT06706622 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Commercially available saline solution
Study NCT06714656 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Food Swap
Description: Personalised food swaps and dietary advice on how to incorporate these swaps into their usual diet
Study NCT06721507 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: tirzepatide
Description: Participants will be educated on dietary and lifestyle changes. Participants will self inject 2.5 mg tirzepatide subcutaneously once weekly and maintain a drug administration diary. Dose escalation will proceed per package directions if instructed by study team at follow up visits.
Study NCT06721507 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Standard of Care
Description: Participants will be educated on dietary and lifestyle changes
Study NCT06729723 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: SAT-001
Description: SAT-001 Treatment Group Participants in this group will use the SAT-001 device for 30 minutes. Before and after using the device, choroidal thickness will be measured using Optical Coherence Tomography (OCT) to assess changes in choroidal thickness.
Study NCT06729723 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: modified SAT-001
Description: mSAT-001 Treatment Group Participants in this group will use the modified SAT-001 (mSAT-001) device for 15 minutes. Similar to the SAT-001 group, choroidal thickness will be measured using Optical Coherence Tomography (OCT) before and after device usage.~This protocol will help evaluate the effect of the SAT-001 and modified device on choroidal thickness, with measurements taken before and after each usage.
Study NCT06738108 — intervention group
Intervention type: DRUG
Intervention: ECOS
Description: The EkoSonic Endovascular System, developed by EKOS Corporation, is a specialized CDT system that combines ultrasound technology with thrombolytic infusion to treat PE
Study NCT06738108 — intervention group
Intervention type: DRUG
Intervention: Control group
Description: Alteplase IV infusion
Study NCT05501496 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: intramedullary nailing
Description: Flexible intramedullary nailing using 2 nails
Study NCT06734234 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: GSK4771261
Description: GSK4771261 will be administered.
Study NCT06734234 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo matching GSK4771261
Description: Placebo matching GSK4771261 will be administered.
Study NCT06749353 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Virtual reality
Description: We will use a virtual reality glasses with the 'Lending Moments' program, where patients can experience a sunset on a paradise beach while listening to a soothing voice that guides them through the experience with relaxation and meditation techniques. During this time, we will proceed with the surgical intervention.
Study NCT06751225 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: One week replacement soft contact lenses
Description: One week replacement soft contact lenses
Study NCT06755411 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: OHFCP2
Description: The proposed intervention consists of a two-phase approach for implementing guidelines and evidence-based recommendations: educating healthcare professionals and enhancing clinical activity.
Study NCT06766643 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Stereotactic Body Radiation Therapy (SBRT)
Description: Stereotactic radiosurgery for liver lesions: with a total dose of 40\~50Gy/3\~5fraction;
Study NCT06766643 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Radiofrequency ablation therapy
Description: Radiofrequency ablation therapy:1 complete radiofrequency ablation of liver lesions for liver lesions
Study NCT06765603 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Atropine 0.025%
Description: Atropine 0.025%
Study NCT06765603 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Atropine 0.025%
Description: Atropine 0.025%
Study NCT06765603 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Multizonal contact lens
Description: Multizonal CL
Study NCT06765603 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Placebo
Description: Placebo
Study NCT06765603 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Placebo
Study NCT06765603 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Single vision Contact lens
Description: Single vision contact lens
Study NCT06765603 — intervention group
Intervention type: DEVICE
Group type: PLACEBO_COMPARATOR
Intervention: Single vision Contact lens
Description: Single vision contact lens
Study NCT04278651 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Ferumoxytol
Description: 510mg infusion x 2 doses 3-8 days apart
Study NCT04278651 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Ferrous Sulfate
Description: 325mg oral twice daily
Study NCT05588973 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: MEDISKIN cream
Description: MEDISKIN cream with collagen
Study NCT05588973 — intervention group
Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Panthenol cream
Description: Panthenol cream
Study NCT06765837 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: biolase laser
Description: after secondary cleft lip surgery to improve wound healing and prevent scar formation laser was used with group I and Gel was applied to Group II
Study NCT06765837 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: blue m gel
Description: active oxygen releasing gel was used after the secondary cleft lip repair surgery
Study NCT06764563 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Mediterranean Medical Nutrition Therapy (counselling)
Description: The participants in the intervention group will receive dietary guidance on the Mediterranean diet during 9 sessions over six months. The sessions which will be held in groups of ten individuals. In-person group sessions will be held three times: at the first meeting, after three months, and after six months. During the remaining six sessions, 6 online video sessions (by the institutional telemedicine program) will be delivered and include 60 minutes of nutritional educational sessions with a registered dietitian once a month
Study NCT06766292 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: primary intervention
Description: In the study group: 2.0 mm screws were fixed to the lateral wall of the sinus above the superior osteotomy and placed buccopalatally where the schneiderian membrane was elevated and maintained. this technique will suspends the membrane in position to allow the blood clot to organized and formation of bone.
Study NCT06766292 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: open sinus lifting with xenograft only
Description: ll Patients in this group underwent open sinus procedures to lift the sinus membrane followed by application of the xenograft as an augmentation material xenograft is used instead of autogenous bone graft to avoid the morbidity of the donor side
Study NCT06766188 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Online Video training for Teachers based on Reading for all
Description: Reading intervention over a year for students with intellectual disabilities who use AAC. There will be 80 participating students and their teachers. It is two arms in the intervention, with approximately 40 in video training for teachers and in person mentoring for teachers. The teachers are randomized into these two groups, but they will carry out the same intervention.~The students in both groups will work explicitly and systematically with the reading material Reading for all, which is based on the research of, among others, Janice Light and David McNaughton, and their reading program Accessible Literacy Learning (ALL).
Study NCT06766188 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Online Video training for Teachers based on Reading for all
Description: Reading intervention over a year for students with intellectual disabilities who use AAC. There will be 80 participating students and their teachers. It is two arms in the intervention, with approximately 40 in video training for teachers and in person mentoring for teachers. The teachers are randomized into these two groups, but they will carry out the same intervention.~The students in both groups will work explicitly and systematically with the reading material Reading for all, which is based on the research of, among others, Janice Light and David McNaughton, and their reading program Accessible Literacy Learning (ALL).
Study NCT06768164 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Billroth 2 (B2)
Description: B2 technique requires a single anastomosis (gastro-jejunostomy) after distal gastrectomy
Study NCT06768164 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Roux-En-Y (REY)
Description: REY technique requires 2 anastomoses (gastro-jejunostomy and entero-enterostomy) after distal gastrectomy
Study NCT06769308 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Sedation titration according to qEEG
Description: Sedation will be titrated according to the EEG derived indexes (qCON/qNOX)
Study NCT06769308 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Sedation titration according to standard of care
Description: Sedation will be provided according to the standard of care of the unit (clinical scales)
Study NCT06769282 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Experimental: Intervention (SPARE) plus Treatment as Usual
Description: 5 components: (1) Social skills training, including selecting healthy friends and partners, (2) Problem solving with emphasis on positive outcomes of nonaggressive solutions, (3) Awareness of domineering behavior in self and conflict resolution skills, (4) emotion Regulation, and (5) psycho-education on ACEs and trauma. Each session will include 30 minutes of didactic instruction on the component with developmentally engaging activities to illustrate concepts and an individually tailored 15-minute narrative and mindfulness activity, which may address a traumatic memory depending on youth need and receptivity.
Study NCT06769282 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Treatment as Usual (TAU)
Description: Treatment As Usual consists of individual, family, occupational, and art therapy, social skills and emotion regulation groups, and therapeutic milieu. All staff and clinicians are trained in the Incredible Years Parenting Program, which aims reduce behavioral problems, enhance children's social and emotional competence, and improve child-parent interactions. Children also receive individualized treatment tailored for their needs (e.g., sleep interventions). Behavioral health needs staff (BHS) facilitate children's skill acquisition and generalization, implement individualized behavior contingency programs, and assist caregivers with parenting strategies via daily check-ins
Study NCT06767644 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: music
Description: In the music group, music chosen by the participant will be played through a speaker by the nursing staff during outpatient hysteroscopy. Music will be played through a speaker instead of headphones in order to maintain good communication and interaction between the participant and the doctor.
Study NCT06767644 — intervention group
Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: no music
Description: Participants in the non-music group will undergo outpatient hysteroscopy in the same setting and standard procedure without listening to any music.
Study NCT06767540 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Placebo
Description: placebo subcutaneous injection Q2W until week 46.
Study NCT06767540 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: placebo
Description: placebo subcutaneous injection Q3W until week 45.
Study NCT06768840 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Baricitinib
Description: oral baricitinib 4mg for adults and 2mg for children 10-16 years for group A
Study NCT06768840 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: oral mini pulse
Description: pulse dose of oral dexamethasone 2.5mg for adults for two consecutive days per week and half the dose for children
Study NCT06768840 — intervention group
Intervention type: RADIATION
Group type: ACTIVE_COMPARATOR
Intervention: Narrow Band UVB Treatment
Description: narrowband ultraviolet rays B phototherapy two sessions per week
Study NCT06767969 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Acetaminophen
Description: Acetaminophenl 500mg (500mg/50ml) was infused intravenously every 6 hours( a single infusion is completed within 15-30 minutes) from the beginning of endovascular treatment to 48 hours after treatment.
Study NCT06768814 — intervention group
Intervention type: BEHAVIORAL
Group type: OTHER
Intervention: Sub-acute stabilization
Description: The sub-acute stabilization center (SASC) is for people who have had or are at risk for having an opioid overdose and have an encounter with Seattle Fire Department emergency medical services (EMS) in Seattle, WA. Those transported to the SASC are the intervention participants and two comparison groups will be utilized: eligible Seattle EMS patients who opt not to go to the SASC and King County residents, outside of Seattle, who meet the same eligibility criteria. A comparative interrupted time series analysis is planned to study the main effectiveness outcomes. Seattle Fire EMS will assess, refer, and arrange transport participants to the SASC. The SASC will offer an array of services including post-overdose monitoring, utilization of buprenorphine and methadone for the treatment opioid use disorder and opioid withdrawal, linkage to ongoing care for OUD, and provision of harm reduction services and supplies. The length of stay in the SASC will be limited to less than 24 hours.
Study NCT06768203 — intervention group
Intervention type: OTHER
Intervention: umbilical vein catheterization
Description: In our NICU, UVC placement is a sterile bedside procedure carried out by pediatric residents, neonatology fellows, and neonatology specialists, using polyurethane, single-lumen catheters sized according to the infant's weight: 3.5 Fr for those under 1500 g and 5 Fr for those over 1500 g. Catheter placement is performed using the Modified Shukla-Ferrara Formula
Study NCT06768203 — intervention group
Intervention type: OTHER
Intervention: Control
Description: No umbilical vein catheter was inserted in these infants.